Interestingly, LRRK2-mediated transcriptional alterations are also associated with Crohn’s disease, a type of inflammatory bowel disease (Liu et al., 2011), and LRRK2 alleles contributing to both PD and Crohn’s disease have been identified (Hui et al., 2018). Here, LRRK2 is linked to inflammatory bowel disease.